Immunogenicity evaluation of respiratory syncytial virus prefusogenic-F based virus-like-particles consisting of G and M proteins in mice., PMID:40334534
Design of a peptide-based vaccine against human respiratory syncytial virus using a reverse vaccinology approach: evaluation of immunogenicity, antigenicity, allergenicity, and toxicity., PMID:40226615
Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic., PMID:40096248
Development of a genetically modified full-length human respiratory syncytial virus preF protein vaccine., PMID:39874917
Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus., PMID:39852872
Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein., PMID:39591199
Bovine Respiratory Syncytial Virus Nanovaccine Induces Long-Lasting Humoral Immunity in Mice., PMID:39421663
Whole-Genome Sequencing and Genetic Diversity of Human Respiratory Syncytial Virus in Patients with Influenza-like Illness in Sicily (Italy) from 2017 to 2023., PMID:38932144
Virus neutralization assays for human respiratory syncytial virus using airway organoids., PMID:38884678
A Mixture of T-Cell Epitope Peptides Derived from Human Respiratory Syncytial Virus F Protein Conferred Protection in DR1-TCR Tg Mice., PMID:38250890
A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus., PMID:38203585
Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review., PMID:37766160
Neutralising antibodies against human metapneumovirus., PMID:37499668
Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants., PMID:37165859
The HRA2pl fusion peptide exerts in vitro antiviral activity against human respiratory paramyxoviruses and pneumoviruses., PMID:37153148
Identification of a DRB3*011:01-restricted CD4+ T cell response against bovine respiratory syncytial virus fusion protein., PMID:36891302
RBF Protein with MA103 Adjuvant Elicited Protective Immunity against Human Respiratory Syncytial Virus in BALB/c Mice., PMID:36724936
Antibodies face the challenge against human respiratory syncytial virus., PMID:36634618
An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection., PMID:36581658
Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice., PMID:36253219
Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age., PMID:36112582
Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice., PMID:35716595
HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice., PMID:35100303
Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection., PMID:34545126
Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses., PMID:34072332
Antibody development for preventing the human respiratory syncytial virus pathology., PMID:32303184
Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice., PMID:32144542
Sequence Analysis of the Fusion Protein Gene of Human Respiratory Syncytial Virus Circulating in China from 2003 to 2014., PMID:30514963
Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset., PMID:30292456
Patterns of antibody response during natural hRSV infection: insights for the development of new antibody-based therapies., PMID:30111181
Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization., PMID:30110893
Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs., PMID:29733750
Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf., PMID:29445124
Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses., PMID:29217660
The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years., PMID:29213258
Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection., PMID:29187546
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein., PMID:29142300
Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV., PMID:29057917
Molecular evolution of the fusion protein (F) gene in human respiratory syncytial virus subgroup B., PMID:28414106
Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation., PMID:28404847
Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency., PMID:28272978
Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation., PMID:27611367
Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection., PMID:27550346
Influence of antigen conformation and mode of presentation on the antibody and protective responses against human respiratory syncytial virus: relevance for vaccine development., PMID:27055009
Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses., PMID:27009962
Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates., PMID:26772634
Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System., PMID:26719246
Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections., PMID:26268314
Genetic variability in G2 and F2 region between biological clones of human respiratory syncytial virus with or without host immune selection pressure., PMID:25742274
The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals., PMID:25738581
For research use only. Not for human or drug use.
